ESTIMATION OF THE SIGNIFICANCE OF POLYMORPHIC ALLELIC VARIANTS OF GENES OF THE HEMOSTASIS SYSTEM VEGFα IN THE DEVELOPMENT OF CEREBVASCULAR DISORDERS
Keywords:
Ischemic stroke, metabolic syndrome, obesityAbstract
Metabolic syndrome - a condition that represents a combination of several factors (hyperinsulinemia, hypertension, dyslipidemia, obesity), which greatly increases the risk of cerebrovascular diseases. In our study, we examined patients with ischemic stroke in the acute phase of the disease - 96 people with metabolic syndrome and without it. It was found significant differences in genetic status in patients with metabolic syndrome on the background with acute ischemic stroke. Alleles and genotypes of the rs2010963 (-634G>C) polymorphisms of the gene (VEGFs) were studied in patients with ischemic stroke with metabolic syndrome and without it;
References
Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance // Circulation. –2007 Mar 13. –115(10). –Р.1285-1295.
Do Espírito Santo G.F., Galera B.B., Duarte E.C., et al. Prognostic significance of vascular endothelial growth factor polymorphisms in colorectal cancerpatients. // World J Gastrointest Oncol. 2017 Feb 15; 9(2):78-86. doi: 10.4251/wjgo.v9.i2.78.
Friedman J.M. Obesity in the new millennium // Nature.-2000. - Vol. 404. - P.632-634.
Hirashima M. Regulation of endothelial cell differentiation and arterial specification by VEGF and Notch signaling // Anat Sci Int. –2009 Sep. –84(3). –Р.95-101. (doi: 10.1007/s12565-009-0026-1.)
Hofmann G., Langsenlehner U., Renner W., et al. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk // J Cancer Res Clin Oncol. 2008 May; 134 (5): 591-5.
Kim J.G., Chae Y.S., Sohn S.K., et al. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patie // Clin Cancer Res. 2008 Jan 1;14(1):62-6. (doi: 10.1158/1078-0432.CCR-07-1537.)
Li L., Liu H., Xu C., at al. VEGF promotes endothelial progenitor cell differentiation and vascular repair through connexin 43 // Stem Cell Res Ther. –2017 Oct 24. –8(1). –Р.237. (doi 10.1186/s13287-017-0684-1.)
Liu F., Luo L., Wei Y., et al. Association of VEGFA polymorphisms with susceptibility and clinical outcome of hepatocellular carcinoma in a Chinese Han population. // Oncotarget. 2017 Mar 7;8(10):16488-16497. doi: 10.18632/oncotarget.14870.
Mackenzie F., Ruhrberg C. Diverse roles for VEGF-A in the nervous system // Development. 2012 Apr; 139(8):1371-80. (doi: 10.1242 / dev. 072348.)
Mattei M.G., Borg J.P., Rosnet O., et al. Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively // Genomics. 1996 Feb 15; 32 (1):168-9.
Mizia-Malarz A., Sobol G., Woś H. [Proangiogenic factors: vascular-endothelial growth factor (VEGF) and basic fibroblast growthfactor--the characteristics and function] // Przegl Lek. –2008. –65(7-8). –Р.353-357.
Poredos P., Jezovnik M.K. Testing endothelial function and its clinical relevance // J Atheroscler Thromb. –2013. –20(1).–Р.1-8.
Schaper W. Collateral circulation: past and present // Basic Res Cardiol. 2009 Jan 104(1):5-21. (doi: 10.1007/s00395-008-0760-x. )
Shibuya M. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor // FEBS J. –2009 Sep. –276(17). –Р.4636-4643. (doi: 10.1111 / j. 1742-4658. 2009. 07175.x.)
Smith J.R., Lanier V.B., Braziel R.M., et al. Expression of vascular endothelial growth factor and its receptors in rosacea. // Br J Ophthalmol. 2007 Feb; 91(2):226-9.
Shim J.W., Madsen J.R. VEGF Signaling in Neurological Disorders // Int J Mol Sci. 2018 Jan 17; 19(1) pii E275. (doi: 10.3390/ijms19010275.)
Tsiskarishvili T., Katsitadze A., Tsiskarishvili N.I., Chigladze V. [Risk-fsctors of cardiovascular disease in patients with rosacea]. // Georgian Med News. 2017 Jan (262):49-52.
Yamasaki K., Gallo R.L. The molecular pathology of rosacea. // J Dermatol Sci. 2009 Aug; 55 (2):77-81. Doi: 10.1016/j.jdermsci.2009.04.007.
Yamamori M., Taniguchi M., Maeda S., et al. VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectaladenocarcinomas in Japanese // Int J Med Sci. 2008 Apr 8;5(2):80-6.
Wei M.H., Popescu N.C., Lerman M.I., et al. Localization of the human vascular endothelial growthfactor gene, VEGF, at chromosome 6p12 // Hum Genet. 1996 Jun 97(6):794-7.
Woo Y.R., Lim J.H., Cho D.H., Park H.J. Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous InflammatoryCondition // Int J Mol Sci. 2016 Sep 15; 17(9) pii: E1562. doi: 10.3390/ijms17091562.
Zachary I. Neuroprotective role of vascular endothelial growth factor: signalling mechanisms, biological function, and therapeutic potential // Neurosignals. 2005 14 (5):207-21.
